- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01594034
Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability and Platelet Aggregation
May 11, 2012 updated by: The University of Texas Health Science Center at San Antonio
Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability
Our objective is to determine whether or not the presence of hemoperitoneum in trauma patients is associated with increased Carbon Monoxide (CO) formation, and to determine if elevated Carbon Monoxide levels are associated with cardiovascular depression, impaired platelet aggregation, and/or multiple organ failure.
Study Overview
Study Type
Observational
Enrollment (Actual)
9
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
San Antonio, Texas, United States, 78229
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
patients in the ICU on a ventilator
Description
Inclusion Criteria:
- Hospitalized males 18 years of age or older,
- Diagnosis of isolated blunt OR blunt and penetrating trauma,
- Admitted or expecting to be admitted to the Intensive Care Unit,
- On mechanical ventilation, and
- Written informed consent obtained
Exclusion Criteria:
- Female gender, (Females will be excluded from this study as the menstrual cycle and other estrogen variations are known to be associated with cyclic changes in CO production adding a potential confounder to the interpretations of our findings.)
- Diagnosis of isolated penetrating trauma,
- Acute hemothorax or pneumothorax,
- Treatment with antiaggregants (ASA, clopidogrel, aggrenox or ticlopidine),
- Enrollment in another research study,
- Prisoners,
- Inability to perform CO measurement within 96 hours after hospital admission.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
no treatment
|
collection of expired air from ventilator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
•Establish a method for reliably measuring CO excretion in patients.
Time Frame: 96 hours
|
96 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Robert Johnson, PhD, University of Texas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
May 1, 2011
Study Completion (Actual)
May 1, 2011
Study Registration Dates
First Submitted
May 4, 2012
First Submitted That Met QC Criteria
May 7, 2012
First Posted (Estimate)
May 8, 2012
Study Record Updates
Last Update Posted (Estimate)
May 14, 2012
Last Update Submitted That Met QC Criteria
May 11, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-2009-0176-H
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemoperitoneum
-
The Guthrie ClinicCompleted
-
Oslo University HospitalRecruitingPostoperative Complications | Ascites | Hemoperitoneum | Intra-Abdominal Fluid CollectionNorway
-
Holy Family Hospital, Nazareth, IsraelRecruitingPostpartum PeriodIsrael
Clinical Trials on expired air
-
University of Alabama at BirminghamCompletedTobacco Smoking | Tobacco Use Disorder | Tobacco Smoking in Mother Complicating PregnancyUnited States
-
AlyatecCompletedAsthma | AllergyFrance
-
Fudan UniversityCompletedInflammation | Blood Pressure | Pulmonary Function | CoagulationChina
-
Assistance Publique - Hôpitaux de ParisVaincre la MucoviscidoseTerminated
-
University of MichiganJRD Enterprises LLC; Michigan Corporate Relations Network Small Company Innovation...CompletedStroke | Spinal Cord Injuries | Healthy AdultsUnited States
-
University of MichiganNational Institute of Environmental Health Sciences (NIEHS)Completed
-
Fudan UniversityActive, not recruiting
-
Tiantian LiCompletedProtective Effect of Air Purifier on Children's HealthChina
-
Massachusetts General HospitalCompletedPerinatal Asphyxia | Asphyxia Neonatorum | Birth Asphyxia
-
University of MichiganNational Institute of Nursing Research (NINR); Michigan State UniversityCompletedCardiometabolic HealthUnited States